University of California, San Diego donations received

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donee information

We do not have any donee information for the donee University of California, San Diego in our system.

Donee donation statistics

Cause areaCountMedianMeanMinimum10th percentile 20th percentile 30th percentile 40th percentile 50th percentile 60th percentile 70th percentile 80th percentile 90th percentile Maximum
Overall 35 312,147 675,700 25,000 100,000 100,000 100,000 137,495 312,147 342,406 750,000 1,001,084 1,602,326 4,748,025
Science 4 326,700 462,865 25,000 25,000 25,000 326,700 326,700 326,700 749,760 749,760 750,000 750,000 750,000
Scientific research 1 54,226 54,226 54,226 54,226 54,226 54,226 54,226 54,226 54,226 54,226 54,226 54,226 54,226
Global health 20 137,495 806,656 100,000 100,000 100,000 100,000 100,000 137,495 342,406 857,110 1,564,515 1,930,642 4,748,025
Financing 2 100,000 714,175 100,000 100,000 100,000 100,000 100,000 100,000 1,328,350 1,328,350 1,328,350 1,328,350 1,328,350
Economics 1 113,940 113,940 113,940 113,940 113,940 113,940 113,940 113,940 113,940 113,940 113,940 113,940 113,940
Digital Technology 1 214,720 214,720 214,720 214,720 214,720 214,720 214,720 214,720 214,720 214,720 214,720 214,720 214,720
Energy and Environment 1 271,207 271,207 271,207 271,207 271,207 271,207 271,207 271,207 271,207 271,207 271,207 271,207 271,207
Evidence-Based Policy 1 312,147 312,147 312,147 312,147 312,147 312,147 312,147 312,147 312,147 312,147 312,147 312,147 312,147
Criminal justice reform 1 322,962 322,962 322,962 322,962 322,962 322,962 322,962 322,962 322,962 322,962 322,962 322,962 322,962
Nutrition 1 343,970 343,970 343,970 343,970 343,970 343,970 343,970 343,970 343,970 343,970 343,970 343,970 343,970
Women's equality organisations and institutions 2 1,001,084 1,301,705 1,001,084 1,001,084 1,001,084 1,001,084 1,001,084 1,001,084 1,602,326 1,602,326 1,602,326 1,602,326 1,602,326

Donation amounts by donor and year for donee University of California, San Diego

Donor Total 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Bill and Melinda Gates Foundation (filter this donee) 20,508,842.00 105,882.00 4,623,555.00 8,981,506.00 658,775.00 2,274,612.00 100,000.00 3,264,512.00 100,000.00 100,000.00 300,000.00
Sloan Foundation (filter this donee) 2,451,327.00 0.00 1,770,967.00 0.00 326,700.00 0.00 0.00 353,660.00 0.00 0.00 0.00
Laura and John Arnold Foundation (filter this donee) 689,335.00 0.00 0.00 635,109.00 0.00 0.00 54,226.00 0.00 0.00 0.00 0.00
Total 23,649,504.00 105,882.00 6,394,522.00 9,616,615.00 985,475.00 2,274,612.00 154,226.00 3,618,172.00 100,000.00 100,000.00 300,000.00

Full list of donations in reverse chronological order (35 donations)

DonorAmount (current USD)Amount rank (out of 35)Donation dateCause areaURLInfluencerNotes
Bill and Melinda Gates Foundation105,882.00242018-04-03Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to help evaluate the utility of in vivo monoclonal antibody expression as a therapy for infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,001,084.0082017-11-07Women's equality organisations and institutionshttps://iatiregistry.org/publisher/bmgf-- to support the development of a Gender Analytics Cell toward generation of high quality analyses of NFHS-4 data on gender outcomes and norms to advance thinking and inform decision-makers at national and sub-national levels; Aid type: Project-type interventions. Affected countries: India.
Bill and Melinda Gates Foundation342,406.00152017-11-03Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to help evaluate the utility of in vivo monoclonal antibody expression as a therapy for infectious diseases; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation137,495.00222017-06-01Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify lead small molecules to treat the neglected tropical disease of schistosomiasis in developing countries; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,328,350.0072017-05-16Financing/Formal sector financial intermediarieshttps://iatiregistry.org/publisher/bmgf-- to catalyze the number of school-age children, in particular girls, attending secondary school by providing the rural poor with access to digital financial services for secure payment and recording of school fees.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252017-04-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to help develop better drugs against the parasite Cryptosporidium, which is a major cause of diarrhea-associated infant deaths in developing countries, by using a genetically-modified yeast strain to identify the target of candidate compounds; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation857,110.0092017-04-10Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to identify natural compounds in human milk that protect infants from environmental enteric disease and diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation857,110.0092017-04-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to identify natural compounds in human milk that protect infants from environmental enteric disease and diarrhea; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Sloan Foundation749,760.00122017Science/Chemistry of Indoor Environmentshttps://sloan.org/grant-detail/8186-- Grant investigator: Vicki Grassian; to investigate the fundamental chemistry of indoor surfaces.
Sloan Foundation271,207.00192017Energy and Environment/https://sloan.org/grant-detail/8249-- Grant investigator: David Victor; to assess the economic, policy, institutional, and technological barriers and opportunities associated with the development and deployment of carbon capture, utilization, and sequestration technologies.
Sloan Foundation750,000.00112017Science/Microbiology of the Built Environmenthttps://sloan.org/grant-detail/8204-- Grant investigator: Robin Knight; to develop and disseminate techniques for 3D mapping of the microbiology and metabolism of built environments.
Bill and Melinda Gates Foundation219,675.00202016-11-15Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to test three promising drug candidates for the potential to protect newborn babies against brain injury and cerebral palsy using a custom experimental model; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,602,326.0042016-11-09Women's equality organisations and institutionshttps://iatiregistry.org/publisher/bmgf-- to identify and address gaps in measurement of gender equity and empowerment, supporting best evidence measures for monitoring and evaluation of programs, policies and initiatives designed to improve gender equity and empowerment; Aid type: Project-type interventions. Affected countries: India.
Bill and Melinda Gates Foundation4,748,025.0012016-11-07Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation2,411,480.0022016-09-22Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a point of care biometric device. Kidprint Phase II. Investment start date: 9/22/2016 to end date: 4/30/2019. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Laura and John Arnold Foundation312,147.00182016Evidence-Based Policyhttp://www.arnoldfoundation.org/grants/-- Grant period: 2016 - 2022. Affected countries: United States; affected states: California.
Laura and John Arnold Foundation322,962.00172016Criminal justice reformhttp://www.arnoldfoundation.org/grants/-- Grant period: 2016 - 2020. Affected countries: United States; affected states: California.
Bill and Melinda Gates Foundation558,775.00132015-07-06Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a technology to quickly and accurately capture and classify fingerprints in rural settings and provide unique identification based on the biometric; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252015-04-13Financing/Formal sector financial intermediarieshttps://iatiregistry.org/publisher/bmgf-- to promote the use of mobile money in West Africa by enabling the low-cost transfer of money safely and directly from individuals to an institution like a school, along with the generation of receipts and transaction records; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Sloan Foundation326,700.00162015Science/Microbiology of the Built Environmenthttps://sloan.org/grant-detail/7755-- Grant investigator: Robin Knight; to develop improved software tools for studying the microbiology of the built environment that integrate sequence data, metabolic data, and building science data.
Bill and Melinda Gates Foundation1,930,642.0032014-11-12Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation343,970.00142014-07-10Nutrition/basic nutritionhttps://iatiregistry.org/publisher/bmgf-- to generate knowledge and public communication of learnings to move the child nutrition field forward; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252013-04-19Global health/malariahttps://iatiregistry.org/publisher/bmgf-- To enable the design of effective combinations of next-generation anti-malarials for overcoming drug resistance by classifying anti-malarial drug candidates using a modified yeast strain displaying enhanced drug sensitivity.; Aid type: Project-type interventions. Affected regions: South of Sahara.
Laura and John Arnold Foundation54,226.00342013Scientific research/research integrityhttp://www.arnoldfoundation.org/grants/-- Grant period: 2013 - 2017. Affected countries: United States; affected states: California.
Bill and Melinda Gates Foundation1,599,997.0052012-10-09Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to accelerate the development of new effective antimalarial drugs through the identification of Plasmodium falciparum targets of novel scaffolds via a chemical genomic approach; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252012-04-17Global health/Reproductive health carehttps://iatiregistry.org/publisher/bmgf-- to develop wireless tattoo-like electronics to continuously monitor vital signs of the pregnant mother and fetus.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation1,564,515.0062012-03-23Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to develop a robust, reproducible set of assays that can be used to identify anti-malarial compounds that prevent the development of gametocytes or have transmission-blocking activities.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Sloan Foundation113,940.00232012Economics/Economic Institutions, Behavior, & Performancehttps://sloan.org/grant-detail/6822-- Grant investigator: John Skrentny; initiative: Economic Analysis of Science and Technology (EAST); to study training and innovation in the science and engineering workforce.
Sloan Foundation214,720.00212012Digital Technology/Scholarly Communicationhttps://sloan.org/grant-detail/6728-- Grant investigator: Philip Bourne; to support a network of practitioners working to transform scholarly communication via online community-building and a "Beyond the PDF 2" workshop.
Sloan Foundation25,000.00352012Science/https://sloan.org/grant-detail/7836-- Grant investigator: Terrence Sejnowski; to provide partial support for the 2012 Sloan-Swartz Annual Meeting on Computational Neuroscience.
Bill and Melinda Gates Foundation100,000.00252011-10-13Global health/basic health carehttps://iatiregistry.org/publisher/bmgf-- to isolate and sequence RNA found in the hair and nails of newborns to uncover nutritional or environmental factors that cause newborn disease.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252010-09-24Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a novel delivery system for non-toxic, anti-roundworm proteins. Novel Delivery of Protein Anthelmintics. Investment start date: 11/1/2010 to end date: 4/30/2012. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
Bill and Melinda Gates Foundation100,000.00252009-09-21Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to create a humanized mouse in which P. falciparum/vivax complete the life cycle. GCE: Humanized Mouse: Recapitulate P. falciparum/vivax Cycle. Investment start date: 11/1/2009 to end date: 7/31/2011. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation100,000.00252009-09-21Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to identify and validate new antigens for natural immune boosting TBV. GCE: Immune Boosting Malaria Transmission Blocking Vaccine (TBV). Investment start date: 11/1/2009 to end date: 6/30/2011. Grantee name: University of California at San Diego; Aid type: Project-type interventions. Affected regions: South of Sahara.
Bill and Melinda Gates Foundation100,000.00252009-02-26Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to develop and test engineered pseudoviruses called TIPs, which conditionally replicate along with the pathogen as it spreads, but have their virulence elements replaced with therapeutic elements that slow disease progression and transmission.; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.